Search alternatives:
driven optimization » design optimization (Expand Search), guided optimization (Expand Search), dose optimization (Expand Search)
based optimization » whale optimization (Expand Search)
library based » laboratory based (Expand Search)
based based » based case (Expand Search), based basis (Expand Search), ranked based (Expand Search)
binary i » binary _ (Expand Search)
i driven » ai driven (Expand Search), _ driven (Expand Search), _ drive (Expand Search)
driven optimization » design optimization (Expand Search), guided optimization (Expand Search), dose optimization (Expand Search)
based optimization » whale optimization (Expand Search)
library based » laboratory based (Expand Search)
based based » based case (Expand Search), based basis (Expand Search), ranked based (Expand Search)
binary i » binary _ (Expand Search)
i driven » ai driven (Expand Search), _ driven (Expand Search), _ drive (Expand Search)
-
121
Box plot comparison on instance j30c5e10.
Published 2025“…Secondly, based on the data libraries of the IPMMPO, two tuple sets suitable for constraint programming modeling are further designed as data preprocessing. …”
-
122
-
123
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small Molecules
Published 2022“…Here, two open-source in-house methodologies for clustering of small molecules are presented: iterative Random subspace Principal Component Analysis clustering (iRaPCA), an iterative approach based on feature bagging, dimensionality reduction, and K-means optimization; and Silhouette Optimized Molecular Clustering (SOMoC), which combines molecular fingerprints with the Uniform Manifold Approximation and Projection (UMAP) and Gaussian Mixture Model algorithm (GMM). …”
-
124
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small Molecules
Published 2022“…Here, two open-source in-house methodologies for clustering of small molecules are presented: iterative Random subspace Principal Component Analysis clustering (iRaPCA), an iterative approach based on feature bagging, dimensionality reduction, and K-means optimization; and Silhouette Optimized Molecular Clustering (SOMoC), which combines molecular fingerprints with the Uniform Manifold Approximation and Projection (UMAP) and Gaussian Mixture Model algorithm (GMM). …”
-
125
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small Molecules
Published 2022“…Here, two open-source in-house methodologies for clustering of small molecules are presented: iterative Random subspace Principal Component Analysis clustering (iRaPCA), an iterative approach based on feature bagging, dimensionality reduction, and K-means optimization; and Silhouette Optimized Molecular Clustering (SOMoC), which combines molecular fingerprints with the Uniform Manifold Approximation and Projection (UMAP) and Gaussian Mixture Model algorithm (GMM). …”
-
126
Acceleration of Inverse Molecular Design by Using Predictive Techniques
Published 2019“…This study addresses one of the most important drawbacks inherently related to molecular searches in chemical compound space by greedy algorithms such as Best First Search and Genetic Algorithm, i.e., the large computational cost required to optimize one or more quantum-chemical properties. …”
-
127
-
128
<b>Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure</b>
Published 2023“…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …”
-
129
Data_Sheet_1_A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.docx
Published 2022“…We performed threshold optimization for converting predicted probabilities into binary predictions and identified the cut-off maximizing the sum of sensitivity and specificity.…”
-
130
-
131
-
132
-
133
Cheminformatics-Guided Cell-Free Exploration of Peptide Natural Products
Published 2024“…To assess the peptide NP space that is directly accessible to current cell-free technologies, we developed a peptide parsing algorithm that breaks down peptide NPs into building blocks based on ribosomal translation logic. …”
-
134
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
-
135
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
-
136
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
-
137
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
-
138
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
-
139
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
-
140
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Published 2025“…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”